gpt-dict.com

鼠李糖乳桿菌 GG Lactobacillus rhamnosus GG (LGG) × 抗生素相關腹瀉

結論：證據支持但有警示

本配對為少數真正具備 strain-exact 高品質證據的益生菌-適應症組合：L2 直接引用 Szajewska 2015（12 RCT, 1499 人，LGG 專屬統合分析，RR 0.

B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示

本配對為少數真正具備 strain-exact 高品質證據的益生菌-適應症組合：L2 直接引用 Szajewska 2015（12 RCT, 1499 人，LGG 專屬統合分析，RR 0.49, 22.4%→12.3%）與 Cai 2018 網絡統合分析（51 RCT, 9569 人，在 10 種益生菌中將 LGG 列為最佳療效與耐受性），兩者皆明確以 LGG (ATCC 53103) 為獨立分析單位而非屬層級泛指。

國際指引收斂支持：WGO 2023 全球指引、NASPGHAN/ESPGHAN 兒科指引皆以 strain-specific 方式建議 LGG ≥10^10 CFU/day 預防 AAD，NIH ODS 亦明確以 LGG 為命名範例引用此 22.4%→12.3% 數據。

雖然 ACG/EFSA 對泛益生菌持保守立場、Examine/Mayo/Harvard 多為屬層級描述，但核心 strain-exact MA 證據與 WGO/NIH/NASPGHAN 之 strain-named 背書已足以支撐 A 級。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.70
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
70%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）

各層「支持此療效」的程度

分數越低＝該層越不支持
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.60
L3 機轉生理合理性
0.65
L11 AI 複核獨立判讀
0.80
L2 PubMed原始文獻
0.85
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.698
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis
PMID: 29511547 2018 Network Meta-analysis
— 詳細結論請見 PubMed 原文
前往 PubMed
Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults
PMID: 26365389 2015 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients - A Systematic Review and Meta-Analysis
PMID: 29023420 2017 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
PMID: 16635227 2006 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review
PMID: 16113542 2005 系統性回顧
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
支持
GRN No. 231 — Notified Substance: Lactobacillus casei subsp. rhamnosus strain GG. Intended Use: Ingredient in term infant formula, at levels not to exceed 10^8 colony forming units per gram of powdered formula. Notifier: Mead Johnson & Company. Agency Response: FDA has no questions (closure date: May 29, 2008). 來源↗
L4b EU EFSA
謹慎
The bacterial species L. rhamnosus (now Lacticaseibacillus rhamnosus) is considered by EFSA to be suitable for the qualified presumption of safety (QPS) approach to safety assessment. However, the EFSA Panel on Dietetic Products, Nutrition and Allergies concluded that a cause and effect relationship has not been established between the consumption of Lactobacillus rhamnosus GG (ATCC 53103, LGG)… 來源↗
L4c UK NHS
中性
Probiotics are generally classed as food rather than medicine, which means they don't go through the rigorous testing medicines do. ... For most people, probiotics appear to be safe. If you want to try them, and you have a healthy immune system, they shouldn't cause any unpleasant side effects. ... If you have an existing health condition or a weakened immune system, you should talk to a doctor… 來源↗
L4d TW TFDA / 衛福部
支持
Lactobacillus rhamnosus is listed in the 'Food Ingredients Available for Use' (可供食品使用原料) comprehensive list as a lactic acid bacterium (乳酸菌), in the form of bacterial cells (菌體), and can be used as a food ingredient or for food processing purposes. 來源↗
L4e WHO
支持
Administration of Lacticaseibacillus rhamnosus GG (LGG) to children with gastroenteritis is recommended by universal guidelines. The World Gastroenterology Organisation's Global Guidelines for Probiotics and Prebiotics (2023 update) lists LGG as having documented, positive results in multiple gut-related health areas. The FAO/WHO Joint Working Group (London, Ontario, 2002) 'Guidelines for the E… 來源↗

L5a NIH Office of Dietary Supplements
支持
Lactobacillus rhamnosus GG is an example where Lactobacillus is the genus, rhamnosus is the species, and GG is the strain. Treatment with LGG compared with placebo or no additional treatment reduced the risk of antibiotic-associated diarrhea in patients treated with antibiotics from 22.4% to 12.3% (relative risk: 0.49). However, when children and adults were evaluated separately, the difference… 來源↗
L5b Mayo Clinic
謹慎
A person might have a reduced chance of having diarrhea related to taking antibiotics, called antibiotic-associated diarrhea, when taking acidophilus along with other specific forms of lactobacillus. It also might lessen diarrhea, bloating and cramps... However, more research needs to be done. 來源↗
L5c Cleveland Clinic
支持
The thing that has really been shown to help the most with preventing diarrhea is taking probiotics when taking antibiotics. ... reviews of studies suggest probiotics are effective both for regular antibiotic-associated diarrhea and for diarrhea related to C. diff. ... The most commonly studied for antibiotic-associated diarrhea are Lactobacillus rhamnosus-based and Saccharomyces boulardii-base… 來源↗
L5d Harvard Health
支持
Those who took antibiotics plus probiotics were 42% less likely to develop diarrhea as those who got the placebo. 來源↗
L5e Specialty Society (condition-mapped)
謹慎
Probiotics and prebiotics for treatment are considered (not recommended). 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

PTT BabyMother 板有家長分享醫師在開立抗生素時加開 LGG 益生菌以預防小兒抗生素腹瀉，屬於菌株特定的臨床用法；但同板多數討論仍偏向泛稱「益生菌」（如妙利散、表飛鳴、寶乖亞等），純粹 LGG / Culturelle 的個人實測心得在台灣社群相對稀少。

💬社群實感

多數正面

破解迷思 社群最常見的 4 個誤解
✓
事實誤以為所有「益生菌」都對抗生素腹瀉同樣有效，忽略菌株差異
✓
事實認為抗生素會殺光益生菌所以同時吃完全無效（忽略間隔 2 小時的做法）
✓
事實把 LGG 跟養樂多 LcS、表飛鳴等其他菌株混為一談
✓
事實認為療程結束就停吃益生菌即可，忽略後續腸道菌相恢復期
🩹 社群通報的副作用
  • 初期偶有腹脹或排氣增加
  • 嬰幼兒偶見便便型態變化
  • 極少數反映無感（可能與菌株/劑量/品牌混淆有關）
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • Culturelle 康萃樂（LGG）
  • 妙利散（CBM588，非 LGG）
  • 表飛鳴（Bifidobacterium，非 LGG）
  • 寶乖亞
  • 摩舒益多
  • 樂亦康（BB536，非 LGG）

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

葡萄王LGG特益菌 — 許可證字號：衛署健食字第A00028號，功效：有助於增加腸內乳酸菌菌數。主要成分為乳酸菌凍乾品 (Lactobacillus rhamnosus GG)。

代表來源 ↗
L10b · TFDA 法定身份 官方認定
✅健康食品（小綠人）

鼠李糖乳酸桿菌（Lactobacillus rhamnosus）被列為微生物及其來源製取之原料，其菌體可供為食品原料或食品加工使用。在台灣，益生菌基本上歸類為「食品」，由食藥署（TFDA）管理，主要規範標示與安全性，避免虛假功效宣稱。若產品要宣稱「輔助調整過敏體質」或「改善胃腸功能」等保健功效，必須通過審查並取得健康食品（小綠人）標章。

來源 ↗

  • 停用或調整抗生素
  • 口服補液 + 益生菌 (Saccharomyces boulardii / LGG)
✓ PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v5 engine_version: v1.0 claim_id: CLM-COND-antibiotic-associated-diarrhea-INT-lactobacillus-rhamnosus-gg-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-antibiotic-associated-diarrhea-INT-lactobacillus-rhamnosus-gg-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "鼠李糖乳桿菌 GG能改善抗生素相關腹瀉",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}